HRT Financial’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.42M Buy
12,200
+1,900
+18% +$443K 0.01% 1485
2025
Q4
$2.76M Buy
10,300
+3,700
+56% +$940K 0.01% 1098
2025
Q3
$1.63M Sell
6,600
-3,700
-36% -$965K 0.01% 1267
2025
Q2
$3.08M Buy
10,300
+7,800
+312% +$2.38M 0.01% 740
2025
Q1
$780K Buy
+2,500
New +$883K ﹤0.01% 1243
2024
Q3
Sell
-3,200
Closed -$970K 2329
2024
Q2
$970K Buy
+3,200
New +$980K 0.01% 1029
2023
Q3
Sell
-700
Closed -$216K 2322
2023
Q2
$216K Buy
+700
New +$203K ﹤0.01% 1804

Other funds holding ACN

HRT Financial's ACN Position: Q1 2026 in Review

HRT Financial sold out of Accenture (ACN) in Q1 2026, closing a stake of 9,399 shares — an estimated $2.19M sold.

HRT Financial first reported a position in ACN in Q2 2018 and held it in 13 quarters. The position peaked at $42.7M in Q2 2024. 2,149 funds tracked by Wall St. Rank hold ACN as of Q1 2026.

  • HRT Financial reported no remaining Accenture position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 9,399 Accenture shares in Q1 2026, an estimated $2.19M.
  • HRT Financial first reported a position in Accenture in Q2 2018 and held it in 13 quarters.
  • HRT Financial's Accenture position peaked at $42.7M in Q2 2024.
  • 2,149 funds tracked by Wall St. Rank held Accenture as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.